Editorial, J Pharm Drug Deliv Res Vol: 6 Issue: 1
Microneedles-Based Devices: Regulatory Insights
| Kasturi Pawar* | |
| Department of Formulation and Product Development, Valeant Pharmaceuticals North America, Petaluma, USA | |
| Corresponding author : Kasturi Pawar, PhD Principal Scientist, Formulation and Product Development Department, Valeant Pharmaceuticals North America, Petaluma, CA 94954, USA E-mail: [email protected] |
|
| Received: March 23, 2017 Accepted: March 24, 2017 Published: March 27, 2017 | |
| Citation: Pawar K (2017) Microneedles-Based Devices: Regulatory Insights. J Pharm Drug Deliv Res 6:1. doi: 10.4172/2325-9604.1000e102 |
Abstract
Microneedles are classic examples of the fact that the pharmaceutical/medical device industry is leading towards a paradigm shift. From past few years, literature and market has been populated with microneedles-based devices claiming a better cosmetic and therapeutic application than existing treatments.
